Cancer Immunotherapy ConsortiumLogo Design Contest

Leading a global effort to improve the standard of patient care by overcoming obstacles to cancer immunotherapy development.

The Cancer Immunotherapy Consortium, a program of the nonprofit Cancer Research Institute, is an association of 70+ academic institutions and companies from the pharmaceutical and biotechnology industries that convenes stakeholders in cancer vaccine and cancer immunotherapy development to discuss the latest advances in development of immune-based cancer therapies and to overcome obstacles to development. Membership in the Consortium provides stakeholders several benefits, including access to industry-leading news, interface with regulatory agency representatives, collaboration opportunities, contribution to position papers addressing important topics in the field, association with the Cancer Research Institute, and opportunities to present data to other field leaders at our annual meetings and conferences.

Would like to see: blues (pmsblue 282 is the Cancer Research Institute (parent organizaton) logo color, so this could be a nice way to associate the CIC logo with the CRI parent logo), white, and perhaps some orange.

The Cancer Immunotherapy Consortium (CIC) is a program of the Cancer Research Institute (CRI). The optimal CIC logo will work well with the CRI logo when they appear together. The CIC was formerly known as the Cancer Vaccine Consortium (CVC). You can read more about it here: http://www.cancerresearch.org/programs/research/Cancer-Vaccine-Consortium.html
The logo currently in place is a direct relation to the CRI logo; however, this time around we are comfortable with a more distinct mark.
This is a global, international group of companies and academics coming together to hash out all the major issues with cancer vaccine and immunotherapy development and regulatory approval.